Literature DB >> 20565154

Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen?

Jeremiah Weinstock1, Carla J Rash, Nancy M Petry.   

Abstract

Contingency management (CM) is an efficacious intervention for cocaine abusing methadone patients, but typically only about half of patients respond. By investigating time to onset of cocaine abstinence and factors associated with abstinence, we may be able to more efficiently direct CM approaches to patients most likely to benefit. Onset of cocaine abstinence was evaluated in cocaine abusing methadone maintenance patients (N = 193) enrolled in one of three randomized clinical trials of CM. Participants received standard treatment with frequent urine toxicology monitoring or standard treatment plus CM during the trials. Slightly more than half the sample obtained at least 1 week of cocaine abstinence, and approximately a third of the sample obtained at least 4 weeks of cocaine abstinence. Discrete-time survival and hazard analyses found Weeks 1 and 2 of the intervention period had the greatest probability for the initiation of abstinence, and few participants initiated any period of abstinence after Week 4. Patients randomized to CM, those with more years of cocaine use, and those with less recent cocaine use were more likely to achieve abstinence. Overall, these results indicate onset of cocaine abstinence is likely to occur early in treatment and in individuals with less severe cocaine use. Practical implications of these results for designing and implementing CM interventions in methadone maintenance clinics are discussed. (PsycINFO Database Record (c) 2010 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20565154      PMCID: PMC2891572          DOI: 10.1037/a0017542

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  35 in total

1.  Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program.

Authors:  N A Piotrowski; D J Tusel; K L Sees; P M Reilly; P Banys; P Meek; S M Hall
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

2.  Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance.

Authors:  K K Downey; T C Helmus; C R Schuster
Journal:  Exp Clin Psychopharmacol       Date:  2000-05       Impact factor: 3.157

3.  The brief abstinence test: effects of continued incentive availability on cocaine abstinence.

Authors:  Elizabeth C Katz; Elias Robles-Sotelo; Christopher J Correia; Kenneth Silverman; Maxine L Stitzer; George Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.157

4.  The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment.

Authors:  P A DeMaria; R Sterling; S P Weinstein
Journal:  Am J Addict       Date:  2000

5.  Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.

Authors:  Mehmet Sofuoglu; Gerardo Gonzalez; James Poling; Thomas R Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2003       Impact factor: 3.829

6.  Shaping cocaine abstinence by successive approximation.

Authors:  K L Preston; A Umbricht; C J Wong; D H Epstein
Journal:  J Consult Clin Psychol       Date:  2001-08

7.  Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.

Authors:  Kyle M Kampman; Joseph R Volpicelli; Frank Mulvaney; Margaret Rukstalis; Arthur I Alterman; Helen Pettinati; Robert M Weinrieb; Charles P O'Brien
Journal:  Addict Behav       Date:  2002 Mar-Apr       Impact factor: 3.913

8.  Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.

Authors:  Nancy M Petry; Bonnie Martin
Journal:  J Consult Clin Psychol       Date:  2002-04

9.  Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.

Authors:  J Dallery; K Silverman; M A Chutuape; G E Bigelow; M L Stitzer
Journal:  Exp Clin Psychopharmacol       Date:  2001-08       Impact factor: 3.157

10.  Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?

Authors:  Nancy M Petry; Jacqueline Tedford; Mark Austin; Charla Nich; Kathleen M Carroll; Bruce J Rounsaville
Journal:  Addiction       Date:  2004-03       Impact factor: 6.526

View more
  8 in total

1.  Prize-based contingency management for the treatment of substance abusers: a meta-analysis.

Authors:  Lois A Benishek; Karen L Dugosh; Kim C Kirby; Jason Matejkowski; Nicolle T Clements; Brittany L Seymour; David S Festinger
Journal:  Addiction       Date:  2014-05-23       Impact factor: 6.526

2.  A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder.

Authors:  Christopher S Stauffer; Vivek Musinipally; Angela Suen; Kara L Lynch; Brad Shapiro; Joshua D Woolley
Journal:  Addict Res Theory       Date:  2016-05-25

Review 3.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

4.  The impact of engagement in street-based income generation activities on stimulant drug use cessation among people who inject drugs.

Authors:  Lianping Ti; Lindsey Richardson; Kora DeBeck; Paul Nguyen; Julio Montaner; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

Review 5.  Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.

Authors:  Carla J Rash; Maxine Stitzer; Jeremiah Weinstock
Journal:  J Subst Abuse Treat       Date:  2016-09-28

6.  Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.

Authors:  Matthew Brensilver; Keith G Heinzerling; Aimee-Noelle Swanson; Steven J Shoptaw
Journal:  Exp Clin Psychopharmacol       Date:  2012-08-06       Impact factor: 3.157

7.  Standard magnitude prize reinforcers can be as efficacious as larger magnitude reinforcers in cocaine-dependent methadone patients.

Authors:  Nancy M Petry; Sheila M Alessi; Danielle Barry; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2014-09-08

8.  Initiation of abstinence in adolescents treated for marijuana use disorders.

Authors:  Pamela C Brown; Alan J Budney; Jeff D Thostenson; Catherine Stanger
Journal:  J Subst Abuse Treat       Date:  2012-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.